Brilliant Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.75 Cr
as on 11-07-2024
- Paid Up Capital ₹ 3.75 Cr
as on 11-07-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 45.96 Cr
as on 11-07-2024
- Satisfied Charges ₹ 19.80 Cr
as on 11-07-2024
- Revenue 24.36%
(FY 2022)
- Profit 225.45%
(FY 2022)
- Ebitda 31.25%
(FY 2022)
- Net Worth 10.88%
(FY 2022)
- Total Assets 14.27%
(FY 2022)
About Brilliant Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.75 Cr and a paid-up capital of Rs 3.75 Cr.
The company currently has active open charges totaling ₹45.96 Cr. The company has closed loans amounting to ₹19.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jigneshkumar Patel and Nitinbhai Raval serve as directors at the Company.
- CIN/LLPIN
U24239GJ2011PTC067706
- Company No.
067706
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Brilliant Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitinbhai Raval  | Director | 23-Jun-2016 | Current |
| Jigneshkumar Patel | Director | 19-Nov-2016 | Current |
Financial Performance of Brilliant Lifesciences.
Brilliant Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.36% increase. The company also saw a substantial improvement in profitability, with a 225.45% increase in profit. The company's net worth Soared by an impressive increase of 10.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brilliant Lifesciences?
Unlock access to Brilliant Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Youth Development Pharmaceutical AssociationActive 4 years 6 months
Nitinbhai Raval is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 16 May 2022 | ₹22.98 Cr | Open |
Bank Of India Creation Date: 14 Feb 2022 | ₹22.98 Cr | Open |
State Bank Of India Creation Date: 05 Jan 2018 | ₹7.86 Cr | Satisfied |
How Many Employees Work at Brilliant Lifesciences?
Brilliant Lifesciences has a workforce of 36 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brilliant Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brilliant Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
